Lestat R Ali
11PUBLICATIONS
91CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Feb 26, 2025
Phase I study of ribociclib (CDK4/6 inhibitor) with spartalizumab (PD-1 inhibitor) with and without fulvestrant in metastatic hormone receptor-positive breast cancer or advanced ovarian cancer.Ana C Garrido-Castro, Noah Graham, Lestat R Ali
|Jul 11, 2024
Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor.Paul E Oberstein, Andressa Dias Costa, Emily A Kawaler
|Sep 21, 2023
PD-1 Blockade Induces Reactivation of Nonproductive T-Cell Responses Characterized by NF-κB Signaling in Patients with Pancreatic Cancer.Lestat R Ali, Patrick J Lenehan, Victoire Cardot-Ruffino
|Mar 07, 2023
cIAP1/2 Antagonism Induces Antigen-Specific T Cell-Dependent Immunity.Katherine S Ventre, Kevin Roehle, Elisa Bello
|Jan 23, 2023
PD-1 blockade and CDK4/6 inhibition augment nonoverlapping features of T cell activation in cancer.Lestat R Ali, Ana C Garrido-Castro, Patrick J Lenehan
|May 20, 2021
cIAP1/2 antagonism eliminates MHC class I-negative tumors through T cell-dependent reprogramming of mononuclear phagocytes.Kevin Roehle, Li Qiang, Katherine S Ventre
Pageof 2
Frequent Collaborators
6 joint publications
Stephanie K Dougan
4 joint publications
Patrick Lenehan
3 joint publications
M Aladdin Bhuiyan
3 joint publications
Shom Goel
3 joint publications
Courtney T Stump
3 joint publications
Katherine S Ventre
3 joint publications
Li Qiang
2 joint publications
Max Heckler
2 joint publications
Kai W Wucherpfennig
2 joint publications
Stephanie J Crowley
